1. Home
  2. ARBB vs BIVI Comparison

ARBB vs BIVI Comparison

Compare ARBB & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

N/A

Current Price

$6.09

Market Cap

10.5M

Sector

Technology

ML Signal

N/A

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.21

Market Cap

8.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBB
BIVI
Founded
1997
2013
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
8.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
ARBB
BIVI
Price
$6.09
$1.21
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
37.6K
130.8K
Earning Date
11-03-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$46,842,655.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$24.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
239.12
N/A
52 Week Low
$3.92
$1.10
52 Week High
$18.60
$22.90

Technical Indicators

Market Signals
Indicator
ARBB
BIVI
Relative Strength Index (RSI) 47.10 37.42
Support Level $5.80 $1.14
Resistance Level $6.21 $1.34
Average True Range (ATR) 0.26 0.09
MACD 0.01 -0.00
Stochastic Oscillator 36.36 26.15

Price Performance

Historical Comparison
ARBB
BIVI

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: